Avanos Medical, Inc.

NYSE:AVNS

24 (USD) • At close September 13, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q32015 Q22015 Q12014 Q42014 Q32014 Q22014 Q12013 Q42013 Q32013 Q22013 Q1
Revenue 171.7166.1173.3171.3169.4191.7217.5202.1203197.4193.4184.1186.4180.7185185.7163.7180.4189.8171.4172.2164.2169.9165.1160.9156.4-584.6401.4399.2395.6410397.5400384.8401.4389.5389.3394.2439.4408.5413.5410.7431.3419.5415.9410.8
Cost of Revenue 76.171.375.975.871.687.2100.69288.190.296.593.7100.789.496.189.977.278.380.176.473.565.469.560.466.265.376.4258.1254.6252.7267.3259.5259.3248.3267.8258.5254.4262.1282.9276.3308.6255.7276258261.9269.4
Gross Profit 95.694.897.495.597.8104.5116.9110.1114.9107.296.990.485.791.388.995.886.5102.1109.79598.798.8100.4104.794.791.1-661143.3144.6142.9142.7138140.7136.5133.6131134.9132.1156.5132.2104.9155155.3161.5154141.4
Gross Profit Ratio 0.5570.5710.5620.5580.5770.5450.5370.5450.5660.5430.5010.4910.460.5050.4810.5160.5280.5660.5780.5540.5730.6020.5910.6340.5890.5821.1310.3570.3620.3610.3480.3470.3520.3550.3330.3360.3470.3350.3560.3240.2540.3770.360.3850.370.344
Reseach & Development Expenses 6.376.86.16.87.97.57.387.87.68.488.39.68.27.79.48.49.69.510.210.610.510.89.910.110.39.881210.99.58.79.810.26.367.58.59.38.313.78.97.87.5
General & Administrative Expenses 0000000000000091.10091.1103.694.494.7106.487.986.379.886.419.2101.2100.1101.2110.1100.3107.992.898.397.2105.897.2126.4111.3101.385.5082.5092.5
Selling & Marketing Expenses 00000000000000-8.90000000000000000000000000000000
SG&A 73.280.468.478.79392.782.682.187.190.175.27576.773.482.282.476.991.1103.694.494.7106.487.986.379.886.419.2101.2100.1101.2110.1100.3107.992.898.397.2105.897.2126.4111.3101.385.584.582.591.992.5
Other Expenses 00-1.3001.30.620.80.1-10.93.48.32241.95.33.710.99.14.36.810.20.9-4.71.84.235.57.44.85.95.71.96.59.30.7-12-1.4-0.7-1.2-0.5-0.5-0.2-2.60.9
Operating Expenses 79.587.475.294.399.9101.990.791.495.99871.986.893103.7133.795.988.3101.5112.9113.1108.5123.4108.797.785.998.133.5114.5115.4116.6126.9117.1123.1103.4114.6116.7112.891.2132.5119.1109.493.397.791.297.1100.9
Operating Income 16.17.422.21.2-2.12.626.218.7199.2253.6-7.3-12.4-44.8-0.1-1.80.6-3.2-18.1-9.8-24.6-8.378.8-7-127.428.829.226.315.820.917.633.120.5-461.222.140.92413.1-4.561.757.670.356.940.5
Operating Income Ratio 0.0940.0450.1280.007-0.0120.0140.120.0930.0940.0470.1290.02-0.039-0.069-0.242-0.001-0.0110.003-0.017-0.106-0.057-0.15-0.0490.0420.055-0.0450.2180.0720.0730.0660.0390.0530.0440.0860.051-1.1840.0570.1040.0550.032-0.0110.150.1340.1680.1370.099
Total Other Income Expenses Net -9.9-5.9-13.3-3.8-3-3-2.3-2.7-2.5-1.3-0.7-0.7-0.9-0.8-2.6-4.1-4.1-3.6-3.3-2.2-1.5-1.3-1.1-2-7.7-7.8-7.2-7.4-7.3-7.2-4.8-5.9-5.7-1.91.5-475.5-0.7121.40.91.210.90.70.40.5
Income Before Tax 6.21.58.9-2.6-5.1-0.423.91616.57.924.32.9-8.2-13.2-47.4-4.2-5.9-3-6.5-20.3-11.3-25.9-9.451.1-14.8-134.621.421.919.17.912.79.425.312.5-46913.332.718.114-3.662.758.57157.341
Income Before Tax Ratio 0.0360.0090.051-0.015-0.03-0.0020.110.0790.0810.040.1260.016-0.044-0.073-0.256-0.023-0.036-0.017-0.034-0.118-0.066-0.158-0.0550.030.007-0.0950.230.0530.0550.0480.0190.0320.0240.0660.031-1.2040.0340.0830.0410.034-0.0090.1530.1360.1690.1380.1
Income Tax Expense 1.91-2.16.2-0.80.170.35.12.114.338-46.1-5.6-0.2-23.5-2.9-6.7-0.4-8.8-3.3-5.6-6.70.8-0.2-3.5-564.84.86.3-2.13.62.911.1-21.55.31120.521.40.921.318.723.118.712.7
Net Income 1.8-0.910.5-3.7-68.1-0.516.915.711.45.810-35.137.9-7.6-47.219.3-33.7-6.1-11.5-8-20.3-2.24.235.320.232.816.617.112.8109.16.514.214.5-470.5821.7-2.4-7.4-4.541.439.847.938.628.3
Net Income Ratio 0.01-0.0050.061-0.022-0.402-0.0030.0780.0780.0560.0290.052-0.1910.203-0.042-0.2550.104-0.0180.021-0.032-0.067-0.046-0.124-0.0130.0250.2190.129-0.0560.0410.0430.0320.0240.0230.0160.0370.036-1.2080.0210.055-0.005-0.018-0.0110.1010.0920.1140.0930.069
EPS 0.039-0.020.23-0.079-1.46-0.0110.360.340.240.120.21-0.730.79-0.16-0.990.4-0.0630.08-0.13-0.24-0.17-0.43-0.0460.090.750.430.70.350.370.270.210.190.140.30.31-10.10.170.47-0.052-0.16-0.10.890.861.030.830.61
EPS Diluted 0.039-0.020.23-0.079-1.46-0.0110.360.330.240.120.21-0.730.78-0.16-0.990.4-0.0630.08-0.13-0.24-0.17-0.43-0.0460.090.730.430.70.350.370.270.210.190.140.30.31-10.090.170.46-0.052-0.16-0.0970.890.861.030.830.61
EBITDA 27.418.833.713.19.915.240.330.630.820.334.513.42.2-2.7-33.910.89.211.99.1-8.10.7-13.83.118.118.81.8-115.545.645.942.932.737.733.948.935.930.638.157.447.840.913.9807587.874.659.7
EBITDA Ratio 0.160.1130.1940.0760.0580.0790.1850.1510.1520.1030.1780.0730.012-0.015-0.1830.0580.0560.0660.048-0.0470.004-0.0840.0180.110.1170.0120.1980.1140.1150.1080.080.0950.0850.1270.0890.0790.0980.1460.1090.10.0340.1950.1740.2090.1790.145